Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. [electronic resource]
Producer: 20120210Description: 123-33 p. digitalISSN:- 1573-7365
- Animals
- Blood -- immunology
- Brain -- immunology
- Disease Models, Animal
- Humans
- Hyaluronan Receptors -- immunology
- Infarction, Middle Cerebral Artery -- pathology
- Lymph Nodes -- immunology
- Male
- Mice
- Mice, Inbred C57BL
- Myelin Proteins -- agonists
- Myelin-Oligodendrocyte Glycoprotein
- Receptors, Antigen, T-Cell -- agonists
- Receptors, CCR5 -- immunology
- Receptors, CCR7 -- immunology
- Recombinant Fusion Proteins -- therapeutic use
- Spleen -- immunology
- T-Lymphocytes -- immunology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.